Role of metal dyshomeostasis in Alzheimer's disease
- 7 February 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Metallomics
- Vol. 3 (3), 267-270
- https://doi.org/10.1039/c0mt00074d
Abstract
Despite serving a crucial purpose in neurobiological function, transition metals play a sinister part in the aging brain, where the abnormal accumulation and distribution of reactive iron, copper, and zinc elicit oxidative stress and macromolecular damage that impedes cellular function. Alzheimer's disease (AD), an age-related neurodegenerative condition, presents marked accumulations of oxidative stress-induced damage, and increasing evidence points to aberrant transition metal homeostasis as a critical factor in its pathogenesis. Amyloid-β oligomerization and fibrillation, considered by many to be the precipitating factor underlying AD onset and development, is also induced by abnormal transition metal activity. We here elaborate on the roles of iron, copper, and zinc in AD and describe the therapeutic implications they present.Keywords
This publication has 50 references indexed in Scilit:
- Alzheimer DiseaseDisease-a-Month, 2010
- Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's DiseaseCell, 2010
- Altered microglial copper homeostasis in a mouse model of Alzheimer’s diseaseJournal of Neurochemistry, 2010
- Mapping Brain Metals to Evaluate Therapies for Neurodegenerative DiseaseCNS Neuroscience & Therapeutics, 2010
- Zinc ions promote Alzheimer Aβ aggregation via population shift of polymorphic statesProceedings of the National Academy of Sciences of the United States of America, 2010
- Nanoparticle and Iron Chelators as a Potential Novel Alzheimer TherapyPublished by Springer Science and Business Media LLC ,2009
- Causes of oxidative stress in Alzheimer diseaseCellular and Molecular Life Sciences, 2007
- Alzheimer disease, the two-hit hypothesis: An updateBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- The Role of Iron and Copper in the Aetiology of Neurodegenerative DisordersCNS Drugs, 2002
- Reduction of the small subunit of Escherichia coli ribonucleotide reductase by hydrazines and hydroxylaminesBiochemistry, 1992